1. Home
  2. ELVN vs BBSI Comparison

ELVN vs BBSI Comparison

Compare ELVN & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • BBSI
  • Stock Information
  • Founded
  • ELVN 2016
  • BBSI 1965
  • Country
  • ELVN United States
  • BBSI United States
  • Employees
  • ELVN N/A
  • BBSI N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • ELVN Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • ELVN 1.2B
  • BBSI 1.1B
  • IPO Year
  • ELVN 2020
  • BBSI 1993
  • Fundamental
  • Price
  • ELVN $20.22
  • BBSI $47.43
  • Analyst Decision
  • ELVN Strong Buy
  • BBSI Strong Buy
  • Analyst Count
  • ELVN 5
  • BBSI 3
  • Target Price
  • ELVN $41.20
  • BBSI $46.33
  • AVG Volume (30 Days)
  • ELVN 335.0K
  • BBSI 156.7K
  • Earning Date
  • ELVN 08-13-2025
  • BBSI 08-06-2025
  • Dividend Yield
  • ELVN N/A
  • BBSI 0.69%
  • EPS Growth
  • ELVN N/A
  • BBSI 10.14
  • EPS
  • ELVN N/A
  • BBSI 2.03
  • Revenue
  • ELVN N/A
  • BBSI $1,199,321,000.00
  • Revenue This Year
  • ELVN N/A
  • BBSI $9.74
  • Revenue Next Year
  • ELVN N/A
  • BBSI $7.40
  • P/E Ratio
  • ELVN N/A
  • BBSI $22.76
  • Revenue Growth
  • ELVN N/A
  • BBSI 9.48
  • 52 Week Low
  • ELVN $13.30
  • BBSI $34.43
  • 52 Week High
  • ELVN $30.03
  • BBSI $48.48
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.43
  • BBSI 56.76
  • Support Level
  • ELVN $19.30
  • BBSI $45.87
  • Resistance Level
  • ELVN $20.28
  • BBSI $47.04
  • Average True Range (ATR)
  • ELVN 1.19
  • BBSI 1.01
  • MACD
  • ELVN 0.15
  • BBSI -0.12
  • Stochastic Oscillator
  • ELVN 59.11
  • BBSI 55.97

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: